Komori
COSMOS Pharmaceutical (3349) · FactCash Balance Updated

Stay-at-Home Demand and Increase in Cash amid the Spread of COVID-19

First written in FY2020. . Latest entry: FY2026.

19entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2020 – FY20262020: 120202021: 320212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Changes in Cash HoldingsA theme 114 companies write about · 70 as a headwind · 63 as a tailwind

65 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 114 companies compared. The sentences above are computed from all 114.
Full recordFilings, disclosures and news, newest first
  1. FY2026Cash Balance UpdatedAnnual report

    「Cash and cash equivalents for the consolidated fiscal year decreased by ¥3,797 million from the end of the previous consolidated fiscal year to ¥53,241 million at the end of the consolidated fiscal year, down 6.7% year on year.」

    Cash and cash equivalents decreased by ¥3,797 million from ¥57,038 million at the end of the previous fiscal year to ¥53,241 million.
  2. FY2026-H1Cash Balance UpdatedAnnual report

    「Cash and cash equivalents at the end of the interim consolidated fiscal period (hereinafter, "funds") decreased by ¥13,797 million from the end of the previous consolidated fiscal year to ¥43,241 million.」

    Cash and cash equivalents decreased by ¥13,797 million from ¥57,038 million at the end of the previous consolidated fiscal year to ¥43,241 million.
  3. FY2025Cash Balance UpdatedAnnual report

    「Cash and cash equivalents for the consolidated fiscal year increased by ¥4,736 million from the end of the previous consolidated fiscal year to ¥57,038 million at the end of the consolidated fiscal year, up 9.1% year on year.」

    Cash and cash equivalents increased from ¥52,301 million at the end of the previous fiscal year to ¥57,038 million.
  4. FY2025-H1Cash Balance UpdatedAnnual report

    「Cash and cash equivalents at the end of the interim consolidated fiscal period (hereinafter, "funds") decreased by ¥13,172 million from the end of the previous consolidated fiscal year to ¥39,129 million.」

    Cash and cash equivalents decreased by ¥13,172 million from ¥52,301 million at the end of the previous consolidated fiscal year to ¥39,129 million.
  5. FY2024Cash Balance UpdatedAnnual report

    「Cash and cash equivalents for the consolidated fiscal year increased by ¥6,373 million from the end of the previous consolidated fiscal year to ¥52,301 million at the end of the consolidated fiscal year, up 13.9% year on year.」

    Cash and cash equivalents increased from ¥45,928 million at the end of the previous fiscal year to ¥52,301 million.
  6. FY2024-Q3Cash Balance UpdatedAnnual report

    「This was mainly due to a ¥27,478 million decrease in cash and deposits, increases of ¥5,028 million in merchandise, ¥1,565 million in other current assets, including accounts receivable, and ¥28,726 million in tangible fixed assets, among other factors.」

    Cash and deposits decreased from ¥45,928 million at the end of the previous consolidated fiscal year to ¥18,450 million, a decrease of ¥27,478 million.
  7. FY2024-Q2Cash Balance UpdatedAnnual report

    「Cash and cash equivalents at the end of the six months ended 30 November (hereinafter, "funds") decreased by ¥16,232 million from the end of the previous consolidated fiscal year to ¥29,696 million.」

    Cash and cash equivalents decreased by ¥16,232 million from ¥45,928 million at the end of the previous consolidated fiscal year to ¥29,696 million.
  8. FY2024-Q1Cash Balance UpdatedAnnual report

    「Cash and deposits 45,928 45,916」

    Cash and deposits decreased from ¥45,928 million at the end of the previous consolidated fiscal year to ¥45,916 million, a decrease of ¥12 million.
  9. FY2023Cash Balance UpdatedAnnual report

    「Cash and cash equivalents for the consolidated fiscal year increased by ¥8,566 million from the end of the previous consolidated fiscal year to ¥45,928 million at the end of the consolidated fiscal year, up 22.9% year on year.」

    Cash and cash equivalents increased from ¥37,362 million at the end of the previous fiscal year to ¥45,928 million.
  10. FY2023-Q3Cash Balance UpdatedAnnual report

    「This was mainly due to a ¥13,014 million decrease in cash and deposits, increases of ¥3,776 million in merchandise, ¥848 million in other current assets, including accounts receivable, ¥21,100 million in tangible fixed assets and ¥855 million in security deposits and guarantee deposits, among other factors.」

    Cash and deposits decreased from ¥37,362 million at the end of the previous consolidated fiscal year to ¥24,347 million, a decrease of ¥13,014 million.
  11. FY2023-Q2Cash Balance UpdatedAnnual report

    「Cash and cash equivalents at the end of the six months ended 30 November (hereinafter, "funds") decreased by ¥7,688 million from the end of the previous consolidated fiscal year to ¥29,674 million, down 28.5% year on year.」

    Cash and cash equivalents decreased by ¥7,688 million from ¥37,362 million at the end of the previous fiscal year to ¥29,674 million at the end of the second quarter.
  12. FY2023-Q1Cash Balance UpdatedAnnual report

    「Cash and deposits 37,362 39,717」

    Cash and deposits increased from ¥37,362 million at the end of the previous consolidated fiscal year to ¥39,717 million, an increase of ¥2,355 million.
  13. FY2022Cash Balance UpdatedAnnual report

    「Cash and cash equivalents for the consolidated fiscal year decreased by ¥17,745 million from the end of the previous consolidated fiscal year to ¥37,362 million at the end of the consolidated fiscal year, down 32.2% year on year.」

    Cash and cash equivalents, which increased against a backdrop of stay-at-home demand and other factors, decreased by ¥17,745 million from the end of the previous fiscal year to ¥37,362 million at the end of the fiscal year.
  14. FY2022-Q3Cash Balance UpdatedAnnual report

    「Cash and deposits 55,108 31,274」

    Cash and deposits decreased from ¥55,108 million at the end of the previous consolidated fiscal year to ¥31,274 million, and were also recorded as a ¥23,834 million factor contributing to the decrease in the analysis.
  15. FY2022-Q2Cash Balance UpdatedAnnual report

    「Cash and cash equivalents at the end of the six months ended 30 November (hereinafter, "funds") decreased by ¥13,599 million from the end of the previous consolidated fiscal year to ¥41,508 million, an increase of 4.6% year on year.」

    Cash and cash equivalents, which increased at the end of the previous consolidated fiscal year against a backdrop of stay-at-home demand and other factors, decreased by ¥13,599 million to ¥41,508 million at the end of the second quarter.
  16. FY2021Cash Balance UpdatedAnnual report

    「Cash and deposits stood at ¥55,108 million at the end of the consolidated fiscal year, up 5.7% year on year.」

    Cash and deposits, which increased at the end of the previous fiscal year against a backdrop of stay-at-home demand and other factors, stood at ¥55,108 million at the end of the fiscal year, an increase of ¥2,985 million from the end of the previous fiscal year.
  17. FY2021-Q3Cash Balance UpdatedAnnual report

    「This was mainly due to a ¥5,471 million decrease in cash and deposits, increases of ¥2,382 million in merchandise, ¥1,403 million in tangible fixed assets and ¥711 million in other current assets, including accounts receivable, among other factors.」

    Cash and deposits, which increased due to stay-at-home demand associated with the spread of COVID-19 and other factors, decreased by ¥5,471 million from the end of the previous consolidated fiscal year to ¥46,650 million at the end of the third quarter.
  18. FY2021-Q2Cash Balance UpdatedAnnual report

    「Cash and cash equivalents at the end of the six months ended 30 November (hereinafter, "funds") decreased by ¥12,443 million from the end of the previous consolidated fiscal year to ¥39,678 million, an increase of 130.9% year on year.」

    Cash and deposits, which increased at the end of FY2020 against a backdrop of stay-at-home demand and other factors, decreased by ¥12,443 million from the end of the previous fiscal year to ¥39,678 million at the end of the second quarter.
  19. FY2020First statedAnnual report

    「Current assets at the end of the fiscal year increased mainly because cash and deposits rose as a result of the sharp increase in sales driven by stay-at-home demand associated with the spread of COVID-19.」

    Against a backdrop of a sharp increase in revenue from stay-at-home demand and other factors, cash and deposits stood at ¥52,122 million and current assets at ¥114,150 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stay-at-Home Demand and Increase in Cash amid the Spread of COVID-19 | COSMOS Pharmaceutical Corporation (3349) | Komori